President Trump’s proposed drug tariffs have not impacted the largest pharmaceutical companies, as firms like Novartis claim they will be exempt. Merck has also secured an exemption through a new factory in Delaware, which is expected to shield the company from the tariffs. Wall Street analysts view this as a victory for the pharmaceutical industry.